FEBRUARY 1, 2024
Reducing the Economic Burden of Hospital Admissions in Treating Patients With ABSSSIs
This Special Report reviews the clinical and economic challenges of acute bacterial skin and skin structure infections and describes the efficacy of using dalbavancin in avoiding hospitalization, facilitating quick and early discharge from the emergency department, and reducing costs.
Download to read this article in PDF format:
Reducing the Economic Burden of Hospital Admissions in Treating Patients with ABSSSIs
This article is in PDF format and it requires Adobe Reader.
If you do not have Adobe Reader installed on your computer then please download and install from the link below.
Download Adobe Reader